The main objective of this clinical trial is to identify a variation in visual strategy characterized by both head movements and eye movements of healthy volunteers during a target detection task when images simulating night vision goggles (NVG) are presented, compared to a situation in which the images simulate a natural environment. To highlight changes in environmental scanning with simulated images from NVG, objective measurements will be collected: * eye movements characterized by saccades (speed, latency, and number) for each stimulus * head movements (horizontal angle of the participant's head) for each stimulus and throughout the exposure Participants sit facing a screen (9.90 m x 2.10 m) onto which a virtual scene is projected. The objective is to correctly identify, as quickly as possible, a target stimulus (represented by a tank) that may appear in the scene. They must use the directional arrows on a game controller to indicate whether the tank is moving to the left or to the right. There are four visits involving four viewing conditions in which the task remains the same: * With restricted field of view and a normal scene. * Without restricted field of view and a scene simulating the vision obtained by NVGs. * With restricted field of view and a scene simulating the vision obtained by NVGs. * Without restricted field of view and a normal scene. Regarding the content of the scene, half of the tests in each visit involve a so-called poor scene when fog is simulated, or an enriched scene when there is no fog. Each visit lasts approximately one hour and thirty minutes.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Eye movements characterized by saccades (speed, latency, and number) for each stimulus
Timeframe: Day 1 (Visit 1) and during follow-up visits at Day 2 (Visit 2), Day 3 (Visit 3), and Day 4 (Visit 4)
Head movements (horizontal angle of the participant's head) for each stimulus and throughout the exposure
Timeframe: Day 1 (Visit 1) and during follow-up visits at Day 2 (Visit 2), Day 3 (Visit 3), and Day 4 (Visit 4)